Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for pulmonary hypertension in patients with COVID-19
IRCT20210710051831N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bosentan in pulmonary hypertension (PH) and coronavirus disease 2019 (COVID-19), sponsored by Qazvin University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary hypertension (PH)coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210710051831N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210710051831N1.